Abstract : With the increasing incidence of methicillin resistant Staphylococcus aureus(MRSA),
Introduction
Staphylococcus aureus is one of the most common causes of nosocomial infection like surgical wound infection, blood stream infection, pneumonia etc. The treatment for this bacterium is a problem with the emergence and spread of methicillin resistance gene. Vancomycin is commonly used for treatment of methicillin resistant Staphylococcus aureus (MRSA) 1 . But the incidence of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) has been increasing in various parts of the world 2 . The first reported case of diminished vancomycin susceptibility in a clinical isolate of S. aureus was from Japan in 1997 3 .It was due to decreased availability of the vancomycin for intracellular target molecules. This was in turn caused by unusually thickened cell wall having dipeptides used for binding vancomycin. This was the first observation of vancomycin-intermediate S. aureus (VISA). Since then, there is a steady increase in the number of cases with VISA and VRSA. This has triggered of alarms in the medical community as S. aureus causes life threatening infections in the hospital as well as in the community.The predicted mechanism of van A gene plasmid-mediated transfer from enterococci to S. aureus was later observed for the first time in 5, 9, 10, 11, 12 . The study was undertaken to monitor the vancomycin susceptibility of MRSA from clinical samples in a tertiary care teaching hospital in Kolkata. Barring two cases -one from Kolkata in 2008 13 and the other from Midnapore in 2011 14 , it has not been reported from eastern zone of India to the best of our knowledge. The aim of the present study was to determine the incidence of vancomycin resistance among S. aureus isolates from different clinical specimens and to determine the sensitivity of these isolates to different antimicrobial agents.
II. MATERIAL AND METHODS
A cross sectional study was conducted in a tertiary care teaching hospital of Kolkata, WestBengal, India during the period from August 2009 to July2011.Different clinical specimens like wound swabs, pus, urine, and blood, obtained randomly from inpatients and outpatients of this referral tertiary care hospital were included in the study.
Staphylococci were obtained either as pure culture or as an isolate of a polymicrobial infection. Mannitol salt agar was used as a selective medium for S. aureus. These were incubated at 37°C for 24 hours. S. aureus was identified conventionally based on Gram's stain morphology, colony characteristics, and positive catalase and coagulase tests 15 . The Staphylococcus species were identified on the basis of both slide and tube coagulase test. Slide coagulase was performed for detection of clumping factor present in S. aureus. Tube coagulase test was done for production of free coagulase enzyme. All S. aureus isolates were subjected to susceptibility testing by the Kirby-Bauer disc diffusion method using different antimicrobial agents e.g., penicillin (10 units), chloramphenical (30 μg), clindamycin(2μg),cefotaxime(30μg),ciprofloxacin(5μg), cefoxitin (30μg), co-trimoxazole (25 μg), erythromycin (15 μg), fusidic acid (10 μg), gentamicin (10 μg), linezolid (30μg), mupirocin (5 μg), netilmycin(10 μg ), ofloxacin (5 μg)oxacillin (1μg), piperacillin-tazobactam(100/10), vancomycin (30 μg) (Hi-media).
The MRSA strains were identified using oxacillin disc (1μg), cefoxitin disc (30µg) as reported by various authors 16 and slidex staph latex agglutination tests (bioMerieux) which detects methicilin resistance in Staphylococci based on the production of low-affinity PBP2a, which is encoded by the mecA gene .
Zone diameter of the test strain was measured in millimeter with a template. The isolates were considered vancomycin resistant if the zone of inhibition was 14 mm or less.
The strains found to be resistant to vancomycin by disc diffusion test were resorted to E test (bioMerieux) to determine the minimum inhibitory concentration (MIC) and confirmation of their resistance status.
0.5 McFarland equivalent inoculums, prepared by using 18-24 hrs old culture was inoculated on the Mueller Hinton agar plates on which E test strip was implanted according to the user guideline. Plates were incubated at 35 o C for 24 h before assessing the visible growth. The MIC is the value at which the elliptical zone of inhibition converges on the strips. Isolates with a vancomycin MIC 4 to 8 mg/L were identified as vancomycin-intermediate, isolates with a vancomycin MIC >16 mg/L were identified as vancomycin-resistant S.aureus(CLSI, 2007) 17 . Quality control was performed using the S. aureus ATCC 29213 strain and ATCC 43300 as MRSA control strain.
Institutional Ethics Committee clearance has been obtained before conducting this study. Statistical analysis: The data collected were put into MS-Excel sheets for analysis. Percentages were used for interpretation of the data in this study.
III. RESULT
From the various clinical samples 714 Staphylococcus aureus were isolated during the study period. Among the isolates 280 were MRSA strain (39.1%). Among 280 MRSA, 21strains were found to be resistant to vancomycin by disc diffusion test. Of these strains, 4 were found to be VISA showing an MIC range between 4-6 mg/L, when tested by E test (bioMerieux). " Fig.1 " shows E test finding of VISA 4 strain with MIC of 6mg/L. The MIC for 276 of 280 isolates (98.57%) for vancomycin was ≤2 mg/L indicating vancomycin sensitive strains. None of the isolates were resistant to vancomycin by E test(MIC in the range of 16-64 mg/L). Zone of inhibition of 3 VISA strains were 13mm and one was found 14 mm in disc diffusion method.
All the isolated VISA strains were resistant to penicillin, cefotaxime, co-trimoxazole, cefoxitin, ciprofloxacin, oxacillin, gentamicin, netilmycin, ofloxacin, piperacillin-tazobactam. Linezolid was the most effective drug against VISA showing 100% sensitivity. Fifty percent of VISA were sensitive to clindamycin and fusidic acid. Details of VISA strains was given in " Table  I" 
IV. DISCUSSION
There is a global epidemic of methicillin resistant Staphylococcus aureus (MRSA) giving rise to increased morbidity and mortality. It is now responsible for around 30% or more of all serious infections though this figure varies 10, 18 . There is an increased chance to cause cross infection and MRSA also has the ability to colonize individuals for months and years. Vancomycin was the only answer for those MRSA, so intensive use of this antibiotic might create a considerable selection pressure for emergence of the resistance to this glycopeptide 19 . In this present study 39.21% (280/714) of Staphylococcus aureus were MRSA strains and only 2.09% (21/714) strains were resistant to vancomycin by disc diffusion testing. But a high rate of vancomycin resistance (79.73%) was reported in a study in sikkim 20 but resistance was not substantiated by MIC testing. In our study only 4 (0.56%) strains were found to be VISA when subjected to E test whereas in a study in northern India 6 (0.76%) VISA strains and 2(0.25%) VRSA strains were reported 5 . In this study, incidence of VISA cases has been found in both pediatric and adult age group and it involved both the male and female population. Moreover it has been isolated from different wards like NICU, Surgery and Gynecology wards. So, it can be said that VISA is prevalent in different wards of the hospital involving all age group of patients indicating the magnitude of the problem. This wide distribution of VISA strains is to be kept in mind while formulating treatment policy of infections in the hospital.
Samples were collected from indoor as well as from outdoor patients of this hospital. But we have found the VISA cases only in the hospitalized patients, though there are cases reported from the community in other studies 21 .
In the present study, isolated VISA showed resistance to a wide range of antimicrobial agents. Only linezolid stood as effective drug against all those strains.
MIC of VISA ranges between 4 to 6 mg/L in this study whereas MIC of VISA found in north India 5 were 8mg/L in 4 isolates and 16 mg/L in 2 isolates and VISA strain in South India 10 showed MIC of 5 mg/L . One of the causes of difference of the MIC range may be due to the difference in the procedures. In these two studies MIC was determined by agar dilution method and broth dilution method respectively whereas in our study E test kit was employed.
VRSA strain reported in Kolkata 13 was senisitive to gentamicin and ciprofloxacin but all VISA in our study were resistant to gentamicin and ciprofloxacin and VISA strain isolated in south India 10 were also resistant to these two drugs. VISA strains were found to be multidrug resistant against a large number of currently available antimicrobial agents, thereby reducing the treatment options for the treating clinicians. In the patients in the paediatric age group, it is found that clindamycin is an alternate, safe and cost effective drug than linezolid in case of VISA 22 but in our study only 50% VISA were sensitive to clindamycin. Though the true mechanism of vancomycin resistance in S. aureus is not known, the problem of antibiotic resistance in developing country like ours seems to be related to irrational antibiotic usage as it is easily available at medicine shops without prescription leading to irregular and irrational treatment; improper dosage and inadequate duration of therapy are other common causes in our country. There is also injudicious use of antibiotics in hospitals; uncontrolled use in agriculture, animal husbandry, fisheries; poor implementation of infection control policies and overcrowding in the hospital set up are resulting in building of selective pressure on vancomycin resistance 23 . Moreover, widespread use of vancomycin to treat infections caused by MRSA and other gram-positive cocci has led to the emergence of vancomycin resistance 5 . The current study only indicates the tip of the iceberg. We should undertake more such studies in future to fight against the rising menace of antibiotic resistance. More research should be done to find out better treatment policies, effective and cheaper alternative antibiotics in a developing country like ours. The study findings were shared with the hospital infection control committee to help them formulating a new antibiotic policy so that primary caregivers can use antibiotic rationally. Teicoplanin, another glycopeptides was not tested in this study, so we cannot compare resistance patterns of this drug with that of vancomycin. We have not performed sensitivity against the newer drugs available against S.aureus e.g., Daptomycin,Quinupristin, Tigecycline in this study. These were the short comings of this study. The VISA strains are preserved in glycerol broth and kept at (-20 o C) to detect the presence or absence of the van A gene in future study. 
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VI. Conclusion
For all practical purposes, vancomycin was the only drug available for MRSA till now. The emergence of vancomycin-intermediate staphylococcal isolates in this part of the country is of great concern as hardly any treatment options are left. So, this study emphasizes the need for continuous monitoring of MIC levels of vancomycin in MRSA, and the importance of its rational use in the infection-control practices to prevent transmission of MRSA as well as VISA strains.
